Trials / Conditions / Hearing Loss Ototoxic
Hearing Loss Ototoxic
4 registered clinical trials studyying Hearing Loss Ototoxic — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | The Effect of Cancer Treatments on Speech Perception in Noise, Cognition, and Hearing-Related Quality of Life NCT06551857 | Turku University Hospital | — |
| Completed | SENS-401 to Prevent the Ototoxicity Induced by Cisplatin in Adult Subjects With a Neoplastic Disease NCT05628233 | Sensorion | Phase 2 |
| Completed | Verification of the Efficacy/safety of the Intratympanic Drug Delivery for Hearing Loss NCT04766853 | Seoul National University Hospital | Phase 1 / Phase 2 |
| Completed | Protective Role of N-acetylcisteine From Cisplatin-induced Ototoxicity in Patients With Head and Neck Cancer NCT03400709 | Hospital San Juan de Dios, Santiago | N/A |